- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
3D aids coronary stent planning
Restenosis following stent placement to open a clogged coronary artery happens with alarming frequency.
A contributing factor may be improper placement of the stent.
Two software packages designed to make stent placement more precise and reduce patients' exposure to x-rays and contrast media were introduced in late September at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, DC.
Images created with the Philips' Allura 3D-Coronary Angiography (left) and Siemens' Interventional Cardiac 3D software (right) demonstrate the exact size and shape of diseased coronary vessels. Legends built into the displays indicate the orientation of the blood vessels relative to the cardiac cath systems. Quantitative measurements of the vessel wall can also be displayed.
Siemens' IC3D was shown as a commercial product, having cleared the FDA in July. Philips' Allura 3D-CA was still in FDA review at the start of the conference.
Philips' new software works with the company's latest digital cardiac cath system, the Allura Xper FD20, but it is also compatible with Philips' cardiac equipment built around image intensifiers. Siemens' IC3D product is being paired with the company's Axiom Artis digital cardiac cath system.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
